AIF-regulated oxidative phosphorylation supports lung cancer development.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and mechanistic study with correlative human data
PubMed 31133695 · doi:10.1038/s41422-019-0181-4
What was done
Researchers evaluated the role of apoptosis-inducing factor (AIF) in lung cancer using a Kras(G12D)-driven mouse model with Aif deletion. They examined tumor onset, malignant progression, animal survival, and metabolic shifts between oxidative phosphorylation (OXPHOS) and glycolysis. They performed rescue experiments in Aif-knockout Kras(G12D) mice by re-expressing wild-type AIF or a mutant AIF retaining mitochondrial function but lacking apoptotic activity, and evaluated the association between AIF expression and prognosis in human non-small cell lung cancer (NSCLC) patients.
What was found
Aif deletion in Kras(G12D) mice led to OXPHOS deficiency, a metabolic switch toward glycolysis, delayed tumor onset, decreased malignant progression, and extended survival. This metabolic shift conferred a growth disadvantage in both Kras(G12D) and Kras wild-type cells. Restoring OXPHOS via cell-autonomous re-expression of either wild-type or apoptosis-deficient mutant AIF reversed the survival benefit. High AIF expression was associated with poor prognosis in human NSCLC. No exact quantitative values or sample sizes were reported in the abstract.
Why it matters
The study shows that AIF-dependent mitochondrial respiration and OXPHOS, rather than glycolysis alone, are critical drivers of Kras-mediated lung tumorigenesis. This highlights mitochondrial metabolism as a key dependency and potential therapeutic target in lung cancer.
Limits
The abstract lacks quantitative effect sizes, survival metrics, and sample sizes for both the murine experiments and the human NSCLC cohort. Findings are predominantly derived from mouse models, and human data remain purely correlational without interventional validation.
Cited by
- contradicts All major cancer tumors ferment energy due to mitochondrial dysfunction, and no tumor grows uncontrollably without relying on a fermentation mechanism.